Trial · NCT00430248
Results by group51
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 51
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Subjects Whose Serum Urate Level is <6.0 Milligrams Per Deciliter (mg/dL) at the Final Visit. | Febuxostat 40 mg QD | 45.2 | percentage of subjects | ||
| Percentage of Subjects Whose Serum Urate Level is <6.0 Milligrams Per Deciliter (mg/dL) at the Final Visit. | Febuxostat 80 mg QD | 67.1 | percentage of subjects | ||
| Percentage of Subjects Whose Serum Urate Level is <6.0 Milligrams Per Deciliter (mg/dL) at the Final Visit. | Allopurinol 200 mg or 300 mg QD | 42.1 | percentage of subjects | ||
| Percentage of Renal Impairment Subjects Whose Final Visit Serum Urate Level is <6.0 mg/dl | Febuxostat 40 mg QD | 49.7 | percentage of subjects | ||
| Percentage of Renal Impairment Subjects Whose Final Visit Serum Urate Level is <6.0 mg/dl | Febuxostat 80 mg QD | 71.6 | percentage of subjects | ||
| Percentage of Renal Impairment Subjects Whose Final Visit Serum Urate Level is <6.0 mg/dl | Allopurinol 200 mg or 300 mg QD | 42.3 | percentage of subjects | ||
| Percentage of Subjects Whose Serum Urate Levels Are <6.0 mg/dL at Month 2 Visit. | Febuxostat 40 mg QD | 49.1 | percentage of subjects | ||
| Percentage of Subjects Whose Serum Urate Levels Are <6.0 mg/dL at Month 2 Visit. | Febuxostat 80 mg QD | 74.1 | percentage of subjects | ||
| Percentage of Subjects Whose Serum Urate Levels Are <6.0 mg/dL at Month 2 Visit. | Allopurinol 200 mg or 300 mg QD | 43.2 | percentage of subjects | ||
| Percentage of Subjects Whose Serum Urate Levels Are <6.0 mg/dL at Month 4 Visit. | Febuxostat 40 mg QD | 47.1 | percentage of subjects | ||
| Percentage of Subjects Whose Serum Urate Levels Are <6.0 mg/dL at Month 4 Visit. | Febuxostat 80 mg QD | 75.2 | percentage of subjects | ||
| Percentage of Subjects Whose Serum Urate Levels Are <6.0 mg/dL at Month 4 Visit. | Allopurinol 200 mg or 300 mg QD | 45.5 | percentage of subjects | ||
| Percentage of Subjects Whose Serum Urate Levels Are <6.0 mg/dL at Month 6 Visit. | Febuxostat 40 mg QD | 48.9 | percentage of participants | ||
| Percentage of Subjects Whose Serum Urate Levels Are <6.0 mg/dL at Month 6 Visit. | Febuxostat 80 mg QD | 75.3 | percentage of participants | ||
| Percentage of Subjects Whose Serum Urate Levels Are <6.0 mg/dL at Month 6 Visit. | Allopurinol 200 mg or 300 mg QD | 46.6 | percentage of participants | ||
| Percentage of Subjects Whose Serum Urate Levels Are <5.0 mg/dL at Month 2 Visit. | Febuxostat 40 mg QD | 15.4 | percentage of subjects | ||
| Percentage of Subjects Whose Serum Urate Levels Are <5.0 mg/dL at Month 2 Visit. | Febuxostat 80 mg QD | 45.9 | percentage of subjects | ||
| Percentage of Subjects Whose Serum Urate Levels Are <5.0 mg/dL at Month 2 Visit. | Allopurinol 200 mg or 300 mg QD | 11.7 | percentage of subjects | ||
| Percentage of Subjects Whose Serum Urate Levels Are <5.0 mg/dL at Month 4 Visit. | Febuxostat 40 mg QD | 15.0 | percentage of subjects | ||
| Percentage of Subjects Whose Serum Urate Levels Are <5.0 mg/dL at Month 4 Visit. | Febuxostat 80 mg QD | 51.6 | percentage of subjects |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00430248/results